Innate Pharma Files 6-K with Exhibit 99.1
Ticker: IPHYF · Form: 6-K · Filed: Jan 27, 2025 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | Jan 27, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, 6-K, foreign-private-issuer
TL;DR
Innate Pharma 6-K filed Jan 27, 2025. Exhibit 99.1 included, but some quotes excluded from ref.
AI Summary
Innate Pharma S.A. filed a Form 6-K on January 27, 2025, reporting information as a foreign private issuer. The filing includes Exhibit 99.1, which contains statements from Dr. Shiraj Sen and Dr. Sonia Quaratino, though these specific quotations are excluded from the official filing's incorporation by reference.
Why It Matters
This filing provides updated information for investors regarding Innate Pharma's ongoing disclosures as a foreign private issuer, potentially impacting their investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Innate Pharma S.A. (company) — Registrant
- January 27, 2025 (date) — Filing date
- Dr. Shiraj Sen (person) — Quoted individual in Exhibit 99.1
- Dr. Sonia Quaratino (person) — Quoted individual in Exhibit 99.1
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is January 27, 2025.
What is the Commission File Number for Innate Pharma S.A.?
The Commission File Number for Innate Pharma S.A. is 001-39084.
Which exhibit is included with this Form 6-K?
Exhibit 99.1 is included with this Form 6-K.
Are the quotations from Dr. Shiraj Sen and Dr. Sonia Quaratino incorporated by reference into the filing?
No, the quotations from Dr. Shiraj Sen and Dr. Sonia Quaratino are explicitly excluded from the incorporation by reference in this Form 6-K filing.
Filing Stats: 283 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2025-01-27 07:57:11
Filing Documents
- a6k-iphx250127.htm (6-K) — 10KB
- exhibit991-250127.htm (EX-99.1) — 20KB
- 0001598599-25-000007.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INNATE PHARMA S.A. Date January 27, 2025 By s JONATHAN DICKINSON Name Jonathan Dickinson Title Chairman of the Executive Board and Chief Executive Officer